Contact : info@zylera.com
Latest Press Release
Company Hires Seasoned Executive In Parallel With New Product Launches
Research Triangle Park, NC, November 15, 2011 — Zylera Pharmaceuticals, LLC, a specialty pharmaceutical company that develops, acquires and commercializes prescription pharmaceutical products and dietary supplements and markets those products in the U.S. is pleased to announce the appointment of Matthew V. Phillips as Chief Operating Officer. Prior to joining Zylera Matt was Executive Director…
read more...
BioTech news
Sales & Marketing- Abbott Announces CE Mark for World's Longest Coronary Drug Eluting Stent
- Registry Data Presented at EuroPCR 2013 Confirms the Neovasc Reducer(TM) Improves Cardiovascular Parameters in Refractory Angina Patients
- Accumed Radial Systems, LLC Names Michael Pisano, PhD, as President and Chief Executive Officer
- OrbusNeich seizes Boston Scientific stents in Germany as part of patent infringement proceedings
- Abbott Announces CE Mark for World's Longest Coronary Drug Eluting Stent
- Registry Data Presented at EuroPCR 2013 Confirms the Neovasc Reducer(TM) Improves Cardiovascular Parameters in Refractory Angina Patients
- Accumed Radial Systems, LLC Names Michael Pisano, PhD, as President and Chief Executive Officer
- OrbusNeich seizes Boston Scientific stents in Germany as part of patent infringement proceedings
